Novartis has won a temporary reprieve from generic competition to its big-selling oral multiple sclerosis therapy Gilenya in the US, which accounts for around half its sales. The Swiss pharma group ...

Early evidence for a cough treatment digital therapeutic is compelling. A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour ...